Roxadustat study for kidney oxygen levels in diabetic anemia
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether roxadustat can improve kidney oxygen levels and anemia in people with diabetic kidney disease. It may help if you have anemia from kidney problems and are being considered for medicines like erythropoietin (EPO).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have diabetes and anemia caused by diabetic kidney disease (DKD), and EPO-type treatment is appropriate for you
- You are age 18 to 75
- You have long-standing diabetes (10 years or more) and kidney disease stage 3 to 4
- Your blood sugar marker HbA1c is above 55, and your hemoglobin is under 10 g/dl due to symptoms
- If you are able to become pregnant: you must use effective birth control during the study and for 30 days after the last visit
- You can sign informed consent and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with heart failure, chronic kidney disease, and low red blood cell counts (anemia). It examines how well the drug roxadustat helps over a long period by looking at medical records from people who have already taken it for more than a year.
This study tests whether roxadustat can help improve heart health, nutrition, and reduce inflammation in people on hemodialysis. It may offer a new treatment option for anemia related to kidney disease.
This study tests roxadustat, a medicine that helps the body make more red blood cells, in children and teens with anemia caused by chronic kidney disease. It may help improve anemia and related blood counts, while also monitoring safety.
This study tests whether roxadustat, a medicine for anemia, can also help with bone problems and mood or thinking issues in people on hemodialysis.
This trial tests an investigational drug called roxadustat to see if it can help people with a certain type of low-risk MDS who need frequent red blood cell transfusions. It's for patients who haven't responded to other anemia treatments.
This trial tests whether a drug called roxadustat can help treat muscle loss (sarcopenia) in people on hemodialysis. It aims to see if improving anemia also strengthens muscles.
Hear when a new Diabetes Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.